MAB21L3 and colitis: These data indicate that different dopamine receptor subtypes mediate both pro-and anti-inflammatory activity in the gut and may act differently on discrete types of immune cells, as D5 activation was shown to both decrease colitis by altering M1/M2 ratios and increase Th1/Th17-mediated inflammation.